glp-1 medication storage requirements Peak review: pricing, medications, and what to expect Storing GLP-1: Best Practices For
Description
Persistent or worsening symptoms warrant further evaluation
In the Phase 2 trial, the most common adverse events were gastrointestinal: nausea (up to 25.6% at higher doses), diarrhea (up to 22.0%), vomiting (up to 12.2%), and constipation (up to 11.0%)
If youre on a GLP-1 and experience any of these symptoms, dont dismiss them as normal medication side effects
Serious adverse reactions should be reported to the FDA MedWatch program
